ArticleRedox biology2026
The CYP1A-HSF1 axis alleviates mitochondrial oxidative stress to limit HBO-induced lung endothelial barrier damage.
Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although hyperbaric oxygen (HBO) therapy is an established medical intervention effective for various conditions, prolonged or excessive exposure can induce acute lung injury (ALI), the mechanisms of which remain poorly understood. In this study, we show that expression of CYP1A1 and CYP1A2, two isoforms of the cytochrome P450 (CYP) 1A subfamily, is significantly upregulated in mouse lung tissues and primary mouse lung microvascular endothelial cells (MLVECs) following HBO exposure. Global double knockout of CYP1A1 and CYP1A2 (referred to as CYP1A-deficient mice) exacerbated pulmonary endothelial dysfunction and ALI in response to HBO, whereas CYP1A inducer β-naphthoflavone (BNF) ameliorated these pathological changes. Mechanistically, activation of the heat shock factor 1 (HSF1) signaling pathway mediates the protective effects of CYP1A induction against HBO-induced mitochondrial oxidative stress, mitochondrial dysfunction, and endothelial cell apoptosis. Critically, HSF1 inhibition abolished BNF-induced HSF1 recruitment to the succinate dehydrogenase subunit C (SDHC) promoter, thereby suppressing SDHC transcription in HBO-exposed pulmonary endothelial cells. Furthermore, the HSF1-mediated protection is dependent on succinate dehydrogenase C (SDHC), thereby linking CYP1A upregulation to the preservation of pulmonary endothelial barrier integrity. CYP1A deficiency leads to reduced SDHC expression, resulting in enhanced mitochondrial oxidative stress, impaired mitochondrial function, and increased apoptosis in lung tissues under HBO conditions. Our findings reveal a previously unrecognized protective mechanism in which upregulation of CYP1A serves as an adaptive response against HBO-induced pulmonary endothelial injury by attenuating mitochondrial oxidative stress and restoring mitochondrial homeostasis via the HSF1/SDHC signaling axis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.